Impact of Ivabradine in Decompensated Heart Failure related to
Chemotherapy-induced Cardiomyopathy
- YUSUKE NAKANO
, - HIROHIKO ANDO,
- WATARU SUZUKI,
- HIROFUMI OHASHI,
- YASUSHI SUZUKI,
- HIROAKI TAKASHIMA,
- TETSUYA AMANO
Abstract
In case of decompensated heart failure related to chemotherapy-induced
cardiomyopathy, ivabradine administration could lead to favorable
hemodynamics via the increase of stroke volume with reducing sinus heart
rate. Assessment of the overlap between the E- and A-waves facilitates
understanding the effects of ivabradine in such cases.04 Jan 2021Submitted to Clinical Case Reports 04 Jan 2021Submission Checks Completed
04 Jan 2021Assigned to Editor
31 Jan 2021Reviewer(s) Assigned
12 Feb 2021Review(s) Completed, Editorial Evaluation Pending
22 Feb 2021Editorial Decision: Revise Minor
20 Mar 20211st Revision Received
20 Mar 2021Submission Checks Completed
20 Mar 2021Assigned to Editor
20 Mar 2021Review(s) Completed, Editorial Evaluation Pending
23 Mar 2021Editorial Decision: Accept
